Dalbavancin Real-life Utilization in Diabetic Patients Suffering From Infections (DALBADIA)
Clinical trial NCT04959799 · COMPLETED
Trial details
- NCT number
- NCT04959799
- Sponsor
- Aziende Chimiche Riunite Angelini Francesco S.p.A
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-01-02
- Primary completion
- 2022-05-31
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.